NANOG and breast cancer: Expected staining patterns were demonstrated in control human tissues: seminoma for OCT4 (Figure S4A), normal skin for SOX2 (Figure S4B), seminoma for NANOG (Figure S4C), breast cancer for KLF4 (Figure S4D) and normal prostatic tissue for c-MYC (Figure S4E).